By vgreene, 15 January, 2015 If drug tx inadequate and rhythm control not achievable: AV-node ablation<sup>4</sup> + pacing [IIa/B]
By vgreene, 15 January, 2015 If drug rate control inadequate/sx persist, use rhythm control<sup>4</sup>
By vgreene, 15 January, 2015 Digoxin/combos:<sup>2</sup> Combine BB w/ other drugs, including digoxin; titrate to avoid bradycardia. Digoxin may be combined w/ BB or CCB [IIa/B]
By vgreene, 15 January, 2015 Control rest/exercise heart rate<sup>1</sup> w/ 1st-line agent,<sup>2</sup> no antithrombotic tx (unless HCM)<sup>3</sup>
By vgreene, 15 January, 2015 Resting goal HR ≤80 [IIa/B]; if asymptomatic w/ preserved LV systolic fxn, consider lenient ≤110 [IIb/B]. Adjust to control rate during exertion [I/C]
By vgreene, 15 January, 2015 BB or non-DHP-CCB (diltiazem/verapamil)<sup>2</sup> [I/B]. If COPD, CCB [I/C]; if hyperthyroid, BB preferred [I/C], if cannot be used, then CCB [I/C]
By vgreene, 15 January, 2015 AFib (Nonvalvular) Chronic Outpatient Management: 2014 AHA/ACC/HRS Guideline | epocrates Guideline Synopsis
By vgreene, 15 January, 2015 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. <i>JACC.</i> 2014;64(No.21);e1-76.
By vgreene, 15 January, 2015 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. <i>JACC</i> Vol. 64, No. 21, 2014